Ciloxan is a widely registered ophthalmic antibacterial brand, marketed in 39 countries across Europe, the Americas, Asia, and Oceania. Its active ingredient is ciprofloxacin, classified as a broad-spectrum bactericidal antibacterial agent. This page is written for travellers, expatriates, and family members trying to identify Ciloxan or its local equivalent across borders.
Ciprofloxacin in ophthalmic form is prescribed for bacterial infections of the eye, including bacterial conjunctivitis and corneal ulcer caused by susceptible organisms. The structured indication list further down this page shows the registered uses recognised by the regulators in each market where Ciloxan is sold, which is the most reliable reference for the brand's specific authorised indications.
Because Ciloxan is distributed across a broad set of markets, travellers frequently encounter it abroad — sometimes under the Ciloxan name, sometimes as another ciprofloxacin-containing ophthalmic preparation. Markets where the brand is registered include Brazil, Germany, Australia, Canada, and Hong Kong, but regulatory status, packaging, and prescription pathways vary considerably from country to country. A pharmacist in the destination market can confirm whether a locally available ciprofloxacin eye product corresponds to what was prescribed at home.
Other antibacterial molecules within the same broad-spectrum class are also marketed internationally as ophthalmic preparations under various brand names, although they are not freely interchangeable — choice of agent depends on the suspected organism and clinical context. Anyone using Ciloxan or seeking a comparable product abroad should treat substitution as a clinical question and raise it with a healthcare provider before making any change.
Ciloxan is prescribed for ophthalmic bacterial infections, including bacterial conjunctivitis and corneal ulcer. The active ingredient belongs to a broad-spectrum bactericidal antibacterial class, applied topically to the eye for susceptible infections rather than systemically. The structured indication block further down this page lists each registered use as recognised by the regulators in markets where Ciloxan is sold.
Ciloxan contains ciprofloxacin, a broad-spectrum bactericidal antibacterial agent. Ciprofloxacin is one of the most widely used molecules in its class internationally and circulates under several brand names worldwide, both as ophthalmic preparations and in other formulations for systemic use. The Ciloxan brand specifically refers to the ophthalmic presentation of this molecule.
Ciloxan is registered in 39 countries, spanning Western and Eastern Europe, the Americas, parts of Asia, and Oceania. Representative markets include Brazil, Australia, Germany, Canada, Hong Kong, Ecuador, and France. If your country is not on the list shown on this page, a local pharmacist can usually confirm whether a ciprofloxacin ophthalmic product is available locally under a different brand name.
Ciprofloxacin is sold under multiple brand names worldwide, both as ophthalmic preparations and in other forms intended for systemic use. Other broad-spectrum antibacterial agents within the same class also exist, although they are not freely interchangeable — molecules within a class differ in spectrum and clinical positioning. To identify a local ciprofloxacin product, search the active ingredient on Pill2Trip or ask a pharmacist.
Yes. Ciloxan is a prescription medication in most jurisdictions, and the choice of an antibacterial agent — even a topical one — depends on the specific infection, the suspected organism, and the patient's individual circumstances. Prescription requirements and available brand names also differ between countries, which matters for travellers and expatriates. Any decision to start, continue, or substitute Ciloxan should involve a healthcare provider.
